Table 3:

Pre- and post-implant (at discharge) medication use

Parameter	n/N (%)	Exact 95% confidence interval
Pre-implant medications
Freedom from OAC	66/174 (37.9)	(30.7%, 45.6%)
Freedom from LMW heparin	168/174 (96.6)	(92.6%, 98.7%)
Freedom from anticoagulation (OAC or LMW heparin)	60/174 (34.5)	(27.5%, 42.1%)
Post-implant (at discharge) medications
Freedom from OAC use post-implant	158/175 (90.3)	(84.9%, 94.2%)
Freedom from LMW heparin use post-implant	168/173 (97.1)	(93.4%, 99.1%)
Freedom from anticoagulation (OAC or LMW heparin) use post-implant	151/173 (87.3)	(81.4%, 91.9%)
Freedom from antiplatelet use post-implant	98/171 (57.3)	(49.5%, 64.8%)
Single antiplatelet use	70/171 (40.9)	(33.5%, 48.7%)
Dual antiplatelet use	3/171 (1.8)	(0.4%, 5.0%)

LMW: low molecular weight; OAC: oral anticoagulation.